Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria

Author:

Kulasekararaj Austin1ORCID,Glasmacher Axel23ORCID,Liu Peng4ORCID,Szer Jeff5ORCID,Araten David6ORCID,Rauch Geraldine7ORCID,Gwaltney Chad89ORCID,Sierra J Rafael4ORCID,Lee Jong Wook10ORCID

Affiliation:

1. King’s College Hospital King’s College London, and NIHR/Wellcome Trust King’s Clinical Research Facility London UK

2. AG Life Science Consulting Alfter Germany

3. Department of Medicine III University of Bonn Bonn Germany

4. Alexion Pharmaceuticals, Inc. Boston Massachusetts USA

5. Peter MacCallum Cancer Centre and The Royal Melbourne Hospital Melbourne Australia

6. New York University Grossman School of Medicine New York New York USA

7. Institute of Biometry and Clinical Epidemiology Charité – Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

8. Gwaltney Consulting Westerly Rhode Island USA

9. Brown University Providence Rhode Island USA

10. Seoul St. Mary’s Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

Funder

Alexion Pharmaceuticals

Publisher

Wiley

Subject

Hematology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Paroxysmal nocturnal hemoglobinuria: Where are we going;American Journal of Hematology;2023-03-31

2. Paroxysmal nocturnal hemoglobinuria: Where we stand;American Journal of Hematology;2023-01-16

3. Investigational drugs for immune thrombocytopenia;Expert Opinion on Investigational Drugs;2022-05-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3